Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study

Author:

Bairkdar Majd1ORCID,Chen Enoch Yi-Tung2,Dickman Paul W2,Hesselstrand Roger3,Westerlind Helga1ORCID,Holmqvist Marie14ORCID

Affiliation:

1. Division of Clinical Epidemiology, Department of Medicine, Solna

2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm

3. Department of Clinical Sciences Lund, Section for Rheumatology, Lund University and Skåne University Hospital , Lund

4. Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet , Stockholm, Sweden

Abstract

Abstract Objectives To conduct the first-ever nationwide, population-based cohort study investigating survival patterns of all patients with incident SSc in Sweden compared with matched individuals from the Swedish general population. Methods We used the National Patient Register to identify patients with incident SSc diagnosed between 2004 and 2015 and the Total Population Register to identify comparators (1:5), matched on sex, birth year and residential area. We followed them until death, emigration or the end of 2016. Follow-up of the general population comparators started the same date as their matched patients were included. We estimated all-cause survival using the Kaplan–Meier method, crude mortality rates and hazard ratios (HRs) using flexible parametric models. Results We identified 1139 incident patients with SSc and 5613 matched comparators. The median follow-up was 5.0 years in patients with SSc and 6.0 years for their comparators. During follow-up, 268 deaths occurred in patients with SSc and 554 in their comparators. The 5-year survival was 79.8% and the 10-year survival was 67.7% among patients with SSc vs 92.9% and 84.8%, respectively, for the comparators (P < 0.0001). The mortality rate in patients with SSc was 42.1 per 1000 person-years and 15.8 per 1000 person-years in their comparators, corresponding to an HR of 3.7 (95% CI 2.9, 4.7) at the end of the first year of follow-up and 2.0 (95% CI 1.4, 2.8) at the end of the follow-up period. Conclusion Despite advances in understanding the disease and in diagnostic methods over the past decades, survival is still severely impacted in Swedish patients diagnosed with SSc between 2004 and 2015.

Funder

Swedish Research Council

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference41 articles.

1. Systemic sclerosis;Allanore;Nat Rev Dis Primers,2015

2. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database;Walker;Ann Rheum Dis,2007

3. Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies;Nikpour;Curr Opin Rheumatol,2014

4. Gender-related differences in systemic sclerosis;Hughes;Autoimmun Rev,2020

5. Preliminary criteria for the classification of systemic sclerosis (scleroderma);Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee;Arthritis Rheum,1980

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3